Abstract
Abstract
Background
Elective implant removal (IR) after fracture fixation is one of the most common procedures within (orthopedic) trauma surgery. The rate of surgical site infections (SSIs) in this procedure is quite high, especially below the level of the knee. Antibiotic prophylaxis is not routinely prescribed, even though it has proved to lower SSI rates in other (orthopedic) trauma surgical procedures. The primary objective is to study the effectiveness of a single intravenous dose of 2 g of cefazolin on SSIs after IR following fixation of foot, ankle and/or lower leg fractures.
Methods
This is a multicenter, double-blind placebo controlled trial with a superiority design, including adult patients undergoing elective implant removal after fixation of a fracture of foot, ankle, lower leg or patella. Exclusion criteria are: an active infection, current antibiotic treatment, or a medical condition contraindicating prophylaxis with cefazolin including allergy. Patients are randomized to receive a single preoperative intravenous dose of either 2 g of cefazolin or a placebo (NaCl). The primary analysis will be an intention-to-treat comparison of the proportion of patients with a SSI at 90 days after IR in both groups.
Discussion
If 2 g of prophylactic cefazolin proves to be both effective and cost-effective in preventing SSI, this would have implications for current guidelines. Combined with the high infection rate of IR which previous studies have shown, it would be sufficiently substantiated for guidelines to suggest protocolled use of prophylactic antibiotics in IR of foot, ankle, lower leg or patella.
Trial registration Nederlands Trial Register (NTR): NL8284, registered on 9th of January 2020, https://www.trialregister.nl/trial/8284
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Vos DI, Verhofstad MHJ, Hanson B, van der Graaf Y, van der Werken C. Clinical outcome of implant removal after fracture healing. Design of a prospective multicentre clinical cohort study. BMC Musculoskelet Disord. 2012;13:147.
2. Backes M, Schep NW, Luitse JS, Goslings J, Schepers T. high rates of postoperative wound infection following elective implant removal. Open Orthop J. 2015;9:418–21.
3. Brown BD, Steinert JN, Stelzer JW, Yoon RS, Langford JR, Koval KJ. Increased risk for complications following removal of hardware in patients with liver disease, pilon or pelvic fractures: a regression analysis. Injury. 2017. https://doi.org/10.1016/j.injury.2017.09.030.
4. Agodi A, Auxilia F, Barchitta M, Cristina ML, D’Alessandro D, Mura I, et al. Risk of surgical site infections following hip and knee arthroplasty: results of the ISChIA-GISIO study. Ann DI Ig Med Prev E DI Comunita. 2017;29:422–30.
5. De Jong L, Klem TMAL, Kuijper TM, Roukema GR. Factors affecting the rate of surgical site infection in patients after hemiarthroplasty of the hip following a fracture of the neck of the femur. Bone Jt J. 2017;99B:1088–94.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献